GlassScriptPhysician profile
Melanie L Tew
NPI 1356394704
$1,873.58
in general payments reported to CMS, 2019-2025
21 companies · $16.12 in 2025
The $16.12 reported for 2025 was less than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,552 · 2020: $254 · 2021: $18.06 · 2022: $17.54 · 2024: $15.80 · 2025: $16.12.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $31.92.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $31.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $300.90 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $253.48 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $210.27 | 2019-2020 | |
| Bausch Health US, LLC | $161.47 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $136.80 | 2019-2020 | |
| Neos Therapeutics, LP | $116.72 | 2019 | |
| Shire North American Group INC | $116.43 | 2019 | |
| Avanir Pharmaceuticals, INC. | $99.80 | 2019 | |
| Ironshore Pharmaceuticals INC. | $75.87 | 2019-2020 | |
| Vanda Pharmaceuticals INC. | $49.67 | 2019-2020 | |
| Lundbeck LLC | $49.58 | 2019-2020 | |
| Neurocrine Biosciences, INC. | $49.14 | 2019 | |
| Jazz Pharmaceuticals INC. | $47.72 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $46.09 | 2019 | |
| Arbor Pharmaceuticals, INC. | $42.64 | 2019-2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Adlon Therapeutics L.P. | $36.42 | 2019 | |
| Tris Pharma INC | $26.71 | 2019-2020 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $16.12 | 2025 | Caplyta |
| Brainsway USA INC | $15.80 | 2024 | Brainsway Deep Tms System |
| Vertical Pharmaceuticals, LLC | $12.71 | 2019 | |
| Currax Pharmaceuticals LLC | $9.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melanie Tew listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.